recognizing the community as a unit of identity to committing to long-term processes of sustainability. 8, 9 In addition to expanding the NCI research agenda and approach, CBPR has important implications for the protection of human subjects and, more important, considering how research can benefit high-risk, underserved members of our society and the communities in which they live.
Our stakeholders from racial, ethnic, and socioeconomic groups that experience disparities have voiced ethical concerns about disease prevention, treatment, racism, medical mistrust, and end-of-life decisions that reflect racial, ethnic, and socioeconomic disparities as well as a variety of social barriers to conducting meaningful research. Similar ethical concerns have been voiced at the researcher-community interface nationally. [10] [11] [12] [13] These concerns compel us to address issues from a public health justice perspective; that is, risks and benefits relating to entire high-risk communities rather than only individual study participants. Although the focus on the negative consequences of traditional biomedical research is laudable, it falls far short of what CNPC investigators see as an extended responsibility to our constituencies. This expands the concept of beneficence, one of the pillars of current ethical criteria, to include "community beneficence," which recognizes the rights of communities to engage in active, informed decision making regarding participating in research that may result in reductions of the health disparities they experience.
When we fail to identify and seize opportunities to reduce cancer-related health disparities, including factors that increase the risk of other diseases, we commit "sins of omission," which result in the absence of studies that could confer a high degree of community beneficence, but are rarely done because they are not "required." These "sins" encompass failing to expand understanding of the underlying causes of health inequities, limiting access to research opportunities, failing to intervene meaningfully to reduce community health inequities based on current knowledge, or passively supporting traditional power imbalances between community partners and researchers that inhibit social advances in health equity. Although direct harm to individuals is now rare, "sins of omission" are, in all likelihood, very common. A poorly understood perceptual gap exists among researchers, other stakeholders, and our disparate communities regarding the interpretation and moral balance between these "sins of omission" and the probability of research harm to individuals in biomedical research. This perceptual gap, in turn, may affect participation in research, including intervention trials and the collection of biological specimens from research subjects.
Despite the stated objective that IRBs should take into account the potential benefits of research to address the causes and consequences of health problems, disability, and premature death (in keeping with the norms of "community beneficence"), we believe that their primary objective is to prevent research harm. Although the potential benefits that members of vulnerable populations may derive from CBPR are real, the criteria for evaluating community beneficence are rather abstract and vague. Unlike assessing deleterious effects across studies that receive IRB approval, for which there is both a discernible "numerator" that can be measured (i.e., adverse effects) and a well-defined "denominator" (the total of human subjects recruited into a defined number of protocols) that allow for relatively straightforward computation of "adverse effect" rates, there are no corollary parameters against which we can assess community-level beneficence. It is, therefore, understandable that IRB committees focus on reducing risk, with its straightforward measure of effectiveness, rather than addressing "sins of omission."
Recognition of the problem of "sins of omission" is not [15] [16] [17] So, in the absence of this commitment to CBPR, these studies would simply never be done.
It is important that the IRBs take community beneficence, and the level of deep commitment it implies, into account when making decisions to approve studies Although the potential benefits to the community may be real, the criteria for evaluating community beneficence are more abstract and vague. Indeed, risk (physical, mental, emotional, and legal) is defined almost exclusively in terms of the individual. There is no comparable detailed consideration of risk to the wider community. Without a more detailed consideration of community beneficence and risk, it is not possible to conduct a sophisticated and balanced assessment of relative benefits and costs to individuals and the wider community.
cBPR PRinciPles And theiR oPeRAtionAlizAtion
Although definitions may vary, it is widely agreed that there are nine principles involved in operationalizing of CBPR 8, 9 :
1. Recognize the community as a unit of identity.
2. Build on the strengths and resources within the community.
3. Facilitate a collaborative, equitable partnership in all research phases through an empowering and power sharing process that attends to social inequalities.
4. Foster co-learning and capacity building among all partners.
5. Integrate and achieve a balance between data generation and intervention for the mutual benefit of all partners.
6. Focus on the local relevance of public health problems and on ecological perspectives that attend to multiple determinants of health.
7. Involve systems development in a cyclical and iterative process.
8. Disseminate results to all partners and involve them in the wider dissemination of results.
9. Involve a long-term process and commitment to sustainability.
Examples of how these were operationalized in our five CNPC are presented in Table 1 .
summARy of mAjoR Points
IRBs need to continue being diligent in protecting research participants from possible harm. Still, we also are obliged to take seriously the ethical implications resulting from not conducting research in disparate communities, namely, "sins of omission." We believe that CBPR can serve as a resource for the development and evaluation of new guidelines for community risk and beneficence. These guidelines, in turn, will contribute to more sophisticated and balanced assessments of the relative benefits and costs to individuals and the wider community in which they live that may be associated with specific research proposals.
Future guidelines should be based on the nine principles of CBPR. Table 1 provides examples illustrating the kinds of things that reviewers might want to consider when evaluating adherence to these principles. When the USC team proposed its first community-guided diet and physical activity intervention trials more than 10 years ago, it was virtually impossible to obtain approval from IRBs accustomed to A 501c(3) CBO was formed that acts as a formal voice for the community, has four paid staff, and functions as a subcontractor to the university for the dissemination and implementation phase of the diet and physical activity intervention.
Colorectal outreach project has involved the fostering of community capacity through Alameda Health Services and Highland Hospital to provide removal of identified polyps. In addition, lay health workers and community health navigators have been trained to serve the Afghan community.
A proposal has been submitted to evaluate
Let's Move! using a quasiexperimental communitybased design. The examples provided in Table 1 illustrate how effective the CNPCs can be with respect to conducting authentic CBPR in communities at very high risk of cancer-related health disparities. As these developments occur, the corollary will be to work with our communities to educate our respective IRBs in considering principles of CBPR in their review of applications to conduct biomedical research. In the process, we will acquire a heightened awareness of the difference between meeting the minimal standards of protecting individual human subjects from harm and the larger imperative to avoid "sins of omission." This also holds the promise of rectifying the pervasive imbalance that has occurred because of well-intentioned attempts on the part of IRBs to limit personal risk and institutional liability.
The CNPCs are committed to serving high-risk populations. The communities we serve expect us to make material differences in improving their situation in general and reducing cancer-related risk factors in particular. Indeed, every grant submitted to the National Institutes of Health requires a section on "public health relevance." We need to be held accountable for delivering on this promise. By being held accountable for our ethical responsibility to partner with communities to reduce cancer-related health disparities, we can reduce "sins of omission." Many practical benefits can ensue, including much higher-than-average rates of study recruitment 18 and biospecimen collections from populations that bear the brunt of health disparities. 19 These populations are often characterized as "hard to reach," but our successes demonstrate that they are rather "hardly reached" because their knowledge and experiences are not generally valued and included in the traditional research process.
Our ability to conduct highly relevant studies with remarkably high rates of recruitment, compliance, and adherence 18 to protocols highlights our ability to address this imbalance through our willingness to engage positively and meaningfully with both the IRBs and our community partners. This is in contrast to working with the primary aim of avoiding risk to individual study participants. We believe that working toward this higher ideal of service to high-risk communities would help to remediate many of the problems that the nation is facing in reducing health disparities.
Results obtained through the use of CBPR practices recognize the unique strengths and perspectives of community partners striving together to achieve social justice and sustainability while decreasing the burden of health-related social disparities. This research allows us to expand the concept of beneficence to include "community beneficence"
and to illustrate how avoiding "sins of omission" leads to profoundly better research and health outcomes. In conducting this CBPR, not only have we engaged meaningfully with our community partners, but we also have deepened the understanding between the research team and our IRBs.
Our working relationships are now much more conducive to designing and conducting studies that really matter-both to our communities and to advancing the science of health disparities. Clearly, the principles of transdisciplinary and interdisciplinary research being promoted so heavily by the National Institutes of Health are consistent with principles of CBPR. 20 So, while we are serving our communities by being responsive to their stated needs, we also are advancing the science in ways that would be virtually impossible if we were content to ignore them.
With the increased credibility of CBPR to inform and guide study development and implementation, 4, 14, 20 we may be at a point in history where we will be able to use resources to increase the relevance of research aimed at reducing cancerrelated health disparities. In addition to focusing on the broad rather than the rule. If there is a deviation, there is, yet again, the potential for increasing individuals' risks from research participation for which the IRB will be on heightened alert.
However, in CBPR, the assumption is that researchers and community members will collaborate in the design and execution of a project. Rather than the exception, it is the norm that projects evolve as a result of this collaboration and partnership. As the prevalence of CBPR projects continues to grow, the traditional IRB monitoring procedures may delay and disrupt the partnership, and perhaps undermine the research, thus increasing the possibility of another "sin of omission."
Recommended guidelines And sAfeguARds foR community Risk And Beneficence
Guidelines should include that the project:
1. Addresses an issue that is identified by a diverse and representative mix of community leaders and residents, in collaboration with researchers, as adversely affecting the health and well-being of the community. This can be a documented health disparity, based on disease incidence, stage of disease, and quality and duration of survival. It can also be an issue or circumstance that adversely affects access to primary prevention and quality of life (e.g., access to healthy food outlets and means to engage in physical activity in a safe environment), as well as other screening, diagnostic, treatment, and rehabilitation services. This collaboration between community members and researchers should be based on a consideration by all of the stakeholders of the community's resources and strengths as well as its limitations and challenges.
2. Is based on past and current collaboration with community members.
3. Is monitored and evaluated on a regular basis by members of the community.
4. Includes a plan for sustaining a successful project.
Recommended safeguards
1. That the NCI convene a national conference representing all of the relevant stakeholders to consider these issues in more detail.
2. Perhaps during, and certainly after, this conference, design and administer a systematic survey to collect information from IRBs, researchers, and community stakeholders on their thoughts and experiences regarding human subject procedures to better understand the causes and consequences of "sins of omission."
It is important to emphasize that we are not recommending that all research approaches be transformed to CBPR. Rather, we contend that CBPR principles and guidelines can lead to a more informed, sophisticated, and balanced consideration by
IRBs of whether individual risks are reasonable in relation to anticipated risks and benefits to the wider community.
